Evogene (NASDAQ: EVGN) reported Q3 EPS of ($0.57), versus ($0.51) reported last year. Revenue for the quarter came in at $2.65 million, versus $5.36 million reported last year.

For earnings history and earnings-related data on Evogene (EVGN) click here.